News Hub | News Direct

NextFerm Technologies announces its first commercial delivery of ProteVin™, in the U.S

NextFerm Technologies Ltd.

Company has delivered two tons of raw material to SpaceMilk, a health and wellness brand, expected to launch its ProteVin™ based product during this summer The company marks the achievement of the second strategic milestone (out of five) for 2022. This announcement follows an earlier announcement made this week about initiating ProteVin’s commercial production The Company is expected to continue supplying ProteVin to customers in the coming weeks, and is currently in dialogues with leading food and dietary supplement brands, for the integration of ProteVin™ in their alternative products (Yokneam Illit, June 22, 2022) – NextFerm Technologies Ltd. (TASE:NXFR), a food-tech company developing ProteVin™, a vegan, fermentation-based, non-GMO protein alternative and other innovative yeast-based nutrients, announced today of the first commercial delivery of ProteVin to a U.S customer. The Company delivered 2 tons out of SpaceMilk’s purchase order obtained in July 2021. SpaceMilk (Former PrimaLife Nutrition), is a US health and wellness brand and the first to launch a vegan protein powder based on ProteVin™. This protein powder will enable consumers to enjoy vegan protein with animal like nutritional value and perfect taste. The ProteVin™ brand name will appear on the product label, as the leading nutritional substance in the product. SpaceMilk is expected to be launched and available for sale to end users during the coming summer months, mostly online. The supply of the remaining of the order, as well as other open orders, shall continue during the coming weeks. The delivery of the first purchase order marks the achievement of the second out of five milestones set by the Company for 2022. This announcement follows an earlier announcement made this week about the initiation of commercial production (first milestone). The Company continues to progress towards the completion of its objectives for 2022, which include: increasing market demands, receiving additional purchase orders for ProteVin™ and increasing commercial production capacity from current scale of tens of tons to a scale of hundreds of tons per year in 2023. Boaz Noy, Chief Executive Officer of NextFerm, said: "We are excited to launch ProteVin, our vegan protein, as planned, and supply it to our first customers, who has expressed confidence in the product by placing purchase orders even before production has started. The alternative protein market, is currently estimated at $20 billion, and is expected to grow to about $290 billion by 2035, at an annual growth rate of above 20%. Today, it is indisputable that it is the main growth engine for the global food industry. This growing trend of consuming vegan foods as part of a balanced diet is becoming ever more popular within the general population that considers these foods to be healthier and more sustainable. "We are proud to be one of the leading innovators in the alternative protein B2B market, by offering the only vegan protein with a neutral flavor and animal like nutritional value that allow it to be incorporated into a variety of foods. We are also making progress in meeting the rest of the milestones for 2022, including: dialogues with food and nutrition brands, who are looking into incorporating ProteVin into their alternative product lines in such fields as dairy substitutes, powder premixes, snacks and more. At the same time, we are preparing to increase production capacity to a scale of hundreds of tons per year, in order to respond to the expected increase in demands." About NextFerm Technologies NextFerm Technologies, traded on the Tel Aviv Stock Exchange (TASE:NXFR) is a food-tech company engaged in the research, development, manufacturing and marketing of innovative, functional and vegan yeast-derived, non-GMO protein alternatives for various applications in the food and food supplement markets and the growing market for animal-derived protein alternatives. NextFerm's flagship product is ProteVin™, a vegan, yeast-derived protein with animal-like nutritional value (Amino acid profile BCAA=21%, Leucine=9%, EAA=53% and high digestibility PDCAAS=1) and a neutral flavor. ProteVin™ is designed for a variety of categories in the alternative protein market, which is estimated at USD 20 billion in terms of final products and at USD 3.5 billion in terms of raw materials with an annual growth rate of above 20%, including milk and dairy substitutes, meat substitutes and additional categories such as infant nutrition, adult nutrition, and sports nutrition. Another product currently being sold is Astaferm®, an innovative astaxanthin-based antioxidant derived from yeast that has been sold in the US since the end of 2020 through well-established and leading brands in the food supplement market in the US. In July 2021, the Company received Regulatory marketing approval in Canada. The company has additional products which have been licensed to Lallemand, a global giant focused on yeast. For more information, visit the NextFerm website at: www.nextferm.com Legal Notice Regarding Forward-Looking Statements This announcement also includes forecasts, projections, assessments, estimates and other information which refer to future events and matters, the realization of which is uncertain and not exclusively under the Company’s control (forward-looking information). The main facts and data used to support this information are facts and data regarding the current position of the Company and its businesses (including the scope of sales and levels of profitability, manpower, commercial engagements and more), facts and data regarding the current global position of the Company’s operating segments (including industry-specific financial developments, environmental regulatory developments, the competitive environment, technological developments, the reinsurance market and more), and macro-economic facts and data (including the economic situation both in Israel and around the world, yields in the capital markets, social and state developments and more), all as known by the Company when publishing this announcement. The forward-looking information included above in this announcement is significantly based upon, in addition to the existing information held by the Company, on the Company’s current assessments and expectations of future developments vis-a-vis each one of the aforementioned parameters, and the interconnectedness of each one of these developments. The Company has no certainty that its forecasts and assessments will indeed eventuate, and the Company’s operating results may be materially different than the results assessed or implicit based on that set forth above, inter alia, as a result of a change in any of the aforementioned factors. Contact Details Investor and Media Contact Meirav Gomeh-Bauer +972 54-476-4979 meirav@bauerg.com Company Website https://www.nextferm.com/

June 22, 2022 09:50 AM Eastern Daylight Time

XPOINT ANNOUNCES MAJOR MILESTONE AS XPOINT VERIFY GOES LIVE IN CANADA

Xpoint Technology

Xpoint, the leading geolocation technology company specializing in sports betting, iGaming and gambling in North America, has announced confirmation of a major milestone in the establishment and growth of the business. Xpoint Verify, Xpoint’s real-money gaming geolocation product developed specifically for sportsbook, iGaming and gambling operators, is now live, in-market for the first time in Canada with Xpoint partner SkillOnNet, the online casino operator which launched in Ontario on June 6, 2022. The news that Xpoint Verify is now live comes less than one year since Xpoint was formally unveiled in Las Vegas at the Global Gaming Expo (G2E) 2021. SkillOnNet, operator of some of the world’s most popular online casinos, launched in Ontario with its brands PlayOJO, SlotsMagic and SpinGenie in early June, 2021. Ontario legalized online gaming on April 4, 2022, opening a major new iGaming market that is expected to reach $1billion in revenue over the next two years. “For everyone involved with Xpoint, this is a very significant announcement,” commented Marvin Sanderson, Xpoint CEO and Co-Founder. “We founded Xpoint in 2019, then formally launched the business just eight months ago at G2E, and now we have our first product live in-market, with an outstanding partner in SkillOnNet. Our investors, partners and our team have made this possible, and I want to thank them all for their support and their hard work. Thousands of hours of work by our world-class team have gone into making this moment possible, and we are honored to be supported by a number of investors and partners who share our vision for transforming the geolocation industry – thank you to them for playing such an important role in helping us reach this milestone. “It’s worth noting that this is just the start, the first chapter in our story. In a matter of weeks we’ll also be live in the USA, and then the rollout of both Xpoint Verify, and Xpoint Lite, our geolocation product designed and built for Daily Fantasy Sports (DFS) operators, will continue at pace. We have a very exciting future ahead, and I’m delighted we’ve already reached such an important chapter in our history with SkillOnNet.” “We’re proud to work with Xpoint as our official geolocation technology partner,” said Maor Nutkevitch, Senior Vice President Corporate Development at SkillOnNet. “We were attracted to Xpoint’s technology that helps our consumers engage with our platforms safely and securely, and the fact that our working relationship is rooted in a true partnership.” Xpoint’s innovative geolocation solutions provide technology that enables sportsbooks, iGaming and Daily Fantasy Sports (DFS) operators to meet their regulatory obligations, helping engage with their customers safely and securely. Xpoint Verify is the real money gaming operator’s geolocation product of choice, while Xpoint Lite is specifically designed for DFS operators. Xpoint’s innovation is not just in product design and delivery, it is also inherent in the company’s ability to work with its partners to turn location-based data into business assets, transforming a utility into a business benefit. To find out more, go to www.xpoint.tech. #### ABOUT XPOINT Xpoint provides essential geolocation security solutions and intelligent location-based marketing insights to the global sports betting and iGaming industries. Xpoint’s innovative Verify and Lite platforms ensures partners meet their regulatory geo-compliance obligations, and deliver enhanced value through the generation of location-based data that can drive marketing programs. Recently nominated for two 2022 SBC North America Awards, Xpoint was founded in 2019 and officially unveiled in Las Vegas in 2021, and is led by the company's CEO and Co-Founder Marvin Sanderson, a global sports betting and iGaming industry leader. With North American offices in Toronto, Canada and Miami, Florida, Xpoint is changing the global geolocation market, bringing innovation to an industry that has, to date, viewed geo-compliance as a utility, not a new business opportunity. For more information, visit xpoint.tech and follow LinkedIn and Twitter for regular updates. Contact Details Xpoint Tom Webb +1 512-952-9369 tom.webb@xpoint.tech Company Website https://xpoint.tech/

June 22, 2022 09:00 AM Eastern Daylight Time

First-of-Its-Kind National Canine Cancer Registry Offers Ray of Hope to Dog Lovers

YourUpdateTV

According to the American Veterinary Medical Association, approximately 1 in 4 dogs will, at some stage in their life, develop a tumor, and almost 50% of dogs over age 10 will develop cancer. Recently, Dr. Susan Ettinger, “Dr Sue Cancer Vet”, Veterinary Cancer Specialist and Take C.H.A.R.G.E. Scientific Advisory Board Member, and Lisa Conte, Jaguar Health Founder & CEO, conducted a satellite media tour to talk about the first-of-its-kind national canine cancer registry that offers a ray of hope to dog-lovers everywhere. A video accompanying this announcement is available at: https://youtu.be/UaYbeRw7JGY Designed to be interactive and with open access to academia, the Jaguar Health Canine Cancer: Take C.H.A.R.G.E. ( C anine H ealth A nd R e G istry E xchange), co-sponsored by Jaguar Animal Health, TogoRun, and Ivee, is a first-of-its-kind national Canine Cancer Registry and Canine Cancer Care Index that provides the veterinary community and canine pet owners with important incidence and prevalence data to help guide canine cancer diagnosis and treatment decisions, at no cost. The Registry began with a retrospective review of more than 35,000 anonymous canine patient records uploaded into a secure customized database and more than 830 confirmed cancer diagnoses and is interactive. Protecting dogs from cancer begins with knowing its impact by breed, type, age, gender, and location Powered by animal health software company Ivee (Intelligent Veterinary Enhanced Experience), only information from canine patients that have been diagnosed with cancer is accessed and data is continuously protected. All research and academia related activities are de-identified and anonymized, following all General Data Protection Regulation (GDPR) guidelines, to ensure 100% participant and veterinary information protection. Currently there is no published state-by-state registry in the U.S. documenting canine cancer, while there are multiple regional European registries that exist and serve to inform both the veterinary and human oncology communities. The Registry also includes the first nationwide Gallup survey of pet owners addressing their experience with canine cancer. Canine Cancer Impact on Humans - Dealing with canine cancer has a major impact on dog owners’ well-being, including depression, anxiety, lack of sleep, and missing work or other obligations; for example, 63 percent of respondents reported feeling a lot of stress and 58 percent reported feeling down and depressed a lot during their dog's cancer. And, more than 8 in 10 dog owners favor the creation of a canine cancer registry to better understand the disease and advance treatments The survey found that the incidence – the percent of U.S. dogs newly diagnosed with cancer in 2021 – was approximately five times incidence of newly diagnosed cancer in humans that year, which is startling since researchers have assumed that canine cancer rates mirror human cancer rates. A complementary Index was established based on pet owner responses to this multi-year nationwide Gallup survey assessing pet owner experience with their dog’s cancer diagnosis and treatment. Together the Registry and Index provides the veterinary community with important information to guide canine cancer diagnosis and treatment decisions and support dog owners by improving canine cancer care. The Gallup survey closed on March 30, 2022, with over 3,800 respondents, including over 600 responses from dog owners with canine cancer experience. Canine cancer patient records uploaded to the Registry are updated regularly thanks to ongoing input from participating veterinarians and owners of dogs who have been diagnosed with cancer. If your dog passed away from cancer, you can contribute to building hope for all dog lovers by uploading your canine pet’s medical records as well. How to get involved as a veterinarian: · If you are a veterinarian and interested in having your clinic/practice opt into the Take C.H.A.R.G.E. Registry, please visit TakeChargeRegistry.com to fill out the Veterinarian Practice Registration form. · All research and academia related activities will be de-identified and anonymized to ensure 100% participant and veterinary information protection. · Once you opt in, the Take C.H.A.R.G.E. Registry will have access to all of your current and newly diagnosed canine patients with cancer. These files will be automatically uploaded into the Take C.H.A.R.G.E. Registry in real time, so no further action is needed once you opt in. How to get involved as a dog owner: · If you are a pet owner and have a PDF of your dog's medical records, simply upload them into the Registry by visiting TakeChargeRegistry.com. · If you do not have your dog's medical records, tell your veterinarian about the Registry at your next visit and encourage them to join! · Follow us on our social channels and reshare with your friends! @Take C.H.A.R.G.E. @takechargereg @takechargeregistry --------------------------- About Susan Ettinger Dr. Sue Ettinger is a practicing veterinary cancer specialist, international speaker, book author, and vlogger (video blogger). She is one of approximately 450 board-certified specialists in medical oncology in North America and currently practices at Veterinary Referral and Emergency Center in Norwalk, Connecticut. She is co-founder and Chief Medical Officer of Fidu, a teleconsulting company to bring together general practice veterinarians and boarded veterinary specialists. She received her veterinary training at Cornell University College of Veterinary Medicine. She completed her residency in medical oncology at the Animal Medical Center in NYC in 2003. She was voted the 2019 Western Veterinary Conference (WVC) Small Animal Continuing Educator of the Year and has recently received awards for Exceptional Doctor Performance and the Public Relations Achievement. Also known as Dr Sue Cancer Vet®, Dr. Sue is the co-author of the Second Edition of The Dog Cancer Survival Guide, which is a best-selling book in small animal health for the last several years. She is a frequent contributor to many veterinary publications, including Today’s Veterinary Practice, Today’s Veterinary Business, Clinician’s Brief, Veterinary Team Brief, & DVM360. She also has co-hosted the podcast The Pet Cancer Vet and is a frequent guest on many veterinary podcasts. There are many myths and misconceptions about cancer in dogs and cats. Most cancers are treatable, and there are a variety of treatment options. Dr Sue’s focus is to provide comprehensive and compassionate care. She strives to minimize side effects – from the cancer itself and treatment – to help her patients lead active, normal lives even while undergoing treatment. Her motto is live longer, live well. Dr. Sue is most passionate about raising cancer awareness, and she has developed “ See Something, Do Something, Why Wait? Aspirate.® ” to promote early cancer detection and diagnosis. This cancer awareness initiative for skin and superficial tumors in dogs and cats provides a set of guidelines for pet owners and veterinarians to help identify the best management for skin and subcutaneous (under the skin) masses in dogs and cats. Masses must be sampled and evaluated under a microscope to determine what they are. The sooner we determine whether a mass is cancerous and should be removed, the better for our pets. Most skin and subcutaneous tumors can be cured with surgery alone if diagnosed early when masses are small. Early detection saves lives. Lisa Conte, Jaguar Health Founder & CEO Lisa Conte is the founder, president and chief executive officer, and a member of the board of directors of Jaguar Health, a commercial-stage pharmaceuticals company committed to discovering, developing and commercializing plant-based prescription medicines for urgent global health needs. Mytesi®, the company’s FDA-approved drug product, is a first-in-class, plant-based anti-secretory agent and the first oral drug approved under FDA Botanical Guidance. In 1989, Ms. Conte also founded Shaman Pharmaceuticals, Inc. and has pioneered plant-based prescription medicine investigation and development for more than 30 years, including a recent Entheogen Therapeutics Initiative looking at psychoactive plants for novel cures for mental health disorders; and Napo Therapeutics, S.p.A., a company established in Italy with a focus on the treatment of rare diseases from plant-based prescription medicines under license from Jaguar Health. Ms. Conte is currently a member of the board of directors of the Healing Forest Conservatory and Napo Therapeutics, and serves on the Editorial Advisory Board of Life Science Leader magazine. She holds an M.S. in Physiology and Pharmacology from the University of California, San Diego, and an M.B.A. and A.B. in Biochemistry from Dartmouth College, and is also the parent of two Jack Russell Terriers and a Belgium Warmblood. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 21, 2022 05:00 PM Eastern Daylight Time

Video

The Sweetest (And Most Popular) Fast Food Menu Items Just in Time for Summer

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/6KjRjXrOgxA What do you think of when it comes to summer? Ballgames, vacations, spending time with friends and family and road trips. When you’re on-the-go – from the park to the beach to a game – the return of summer is not complete without a trip (or trips!) to your favorite fast-food restaurant. Now is your chance to find out what the most popular fast food menu items will be this summer. Hint...it will be a berry delicious summer. Wendy’s is always looking at new ways to fuel fast food forward and be true boundary breakers in the industry, and this Strawberry season is no different. The Strawberry Frosty has been added to the Wendy’s menu for a limited-time this summer! If you can believe it, this was the number one requested item from Wendy’s fans. It’s a sweet, strawberry spin on the classic Vanilla Frosty – full of thick, creamy flavorful goodness in every spoonful. When it comes to its summer menu, everything Wendy’s does ladders back to its principles of fresh, real, affordable and forward-leaning, and the return of the Summer Strawberry Chicken Salad as a full-sized entrée is a great example! Fans look forward to this item each year, and as the only hamburger QSR in the game to offer entrée salads, Wendy’s is happy to treat them to a salad they can feel good about eating – full of high-quality, flavorful ingredients. · This salad features: o Wendy’s signature lettuce blend o Sun-ripened, freshly sliced strawberries o Crispy Applewood smoked bacon o All-white meat chicken o Italian Cheese Blend o Candied Almonds o Sweet Champagne vinaigrette But that’s not all! Wendy’s has also added a brand-new offering to the Dave’s Craft Lemonade lineup –he Sunburst Melon Lemonade. It’s light, refreshing and features favored summer flavors like strawberry, watermelon, cantaloupe and kiwi. A taste of summer in every sip. For more information, head to your nearest Wendy’s restaurant or check out the Wendy’s app for more information on our menu, offers, Rewards and more. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 21, 2022 02:00 PM Eastern Daylight Time

Video

NO DOGS LEFT BEHIND TO HOST SILENT AUCTION & COCKTAIL PARTY BENEFITING RESCUE EFFORTS IN UKRAINE & HUNGARY

No Dogs Left Behind

In response to worsening conditions on the ground in Ukraine and Hungary, No Dogs Left Behind (NDLB) will present a very special evening in support of rescue efforts in this war-torn region. Founder Jeffrey Beri has once again heeded the call to assist in an international crisis, operating under the belief that there are no borders in the world of rescue. On Friday, July 15, 2022 from 5 to 7 p.m., join NDLB at St. Ann’s Episcopal Church in Bridgehampton. Bid on fabulous silent auction prizes as you enjoy beer, wine and light bites under the magnificent tent. Tickets are $100 and all funds will go directly toward rescuing and transporting the pups in peril, as well as providing medical care, food and a safe haven as they await being matched with forever families. St. Ann’s – “the little church with the big heart” – is located at 2463 Main Street, Bridgehampton, NY 11932. To RSVP and purchase tickets, visit https://bit.ly/NDLBHAMPTONSTICKETS. We hope you will join us! If you are unable to attend the event but would like to make a donation in support of this work, visit https://bit.ly/NDLBEVENT_VIRTUALSUPPORT to lend your virtual support! For more information, or to inquire about sponsorship opportunities, contact maura@nodogsleftbehind.com or call 631-599-0866. ABOUT THE ORGANIZATION: No Dogs Left Behind (NDLB) operates boots on the ground in East Asia, fighting on the frontlines to rescue dogs from the illegal dogmeat trade. NDLB works hands-on with local activists through emergency response, pulling dogs directly from slaughterhouses, dogmeat trucks, wet markets and traffickers. NDLB’s mission extends beyond borders, organizing international rescue efforts in in war-torn regions, advocating for the creation and enforcement of animal welfare laws, and raising awareness for a cruelty-free, sustainable world in which no animal is violated, exploited, tortured or slaughtered for commercial goods or profit. With nearly 500 survivors in its care, No Dogs Left Behind operates sanctuaries in Dayi and Gongyi in East Asia and Toronto, Canada. Follow us on Facebook, Instagram, YouTube, Twitter, and TikTok. Contact Details No Dogs Left Behind Sherry Sung +1 855-665-0888 sherry@nodogsleftbehind.com Company Website http://www.nodogsleftbehind.com

June 21, 2022 09:35 AM Eastern Daylight Time

Ripken Baseball Adds Its Fourth Ripken Experience™ through Partnership with Elizabethtown Sports Park in Kentucky

Ripken Baseball

Ripken Baseball, the leader in youth sports events, announced it will add its fourth Ripken Experience™ location in the United States through a partnership with Elizabethtown Sports Park in Elizabethtown, Ky. Officially named The Ripken Experience™ Elizabethtown, Ripken Baseball will bring world-class youth baseball and softball tournaments, plus week-long experiences, to the state-of-the-art complex starting in 2023. This year marks Elizabethtown Sports Park’s 10th anniversary since opening the complex, which has attracted 160,000 visitors annually. Within the past decade, Elizabethtown Sports Park has been responsible for generating $150 million in direct economic impact for the city. With the goal of bringing even more teams and families to Elizabethtown, Ripken Baseball will host events on the 12 interchangeable baseball/softball turf fields. “The fields and facilities at Elizabethtown Sports Park are in the top tier of youth complexes in America – a category I believe includes our other Ripken Experience™ locations across the country,” said Cal Ripken, Jr., who founded Ripken Baseball with his brother Bill. “When we think about The Ripken Experience™ Elizabethtown, the key word is experience. Our teams and their families will be treated like big-leaguers, creating lifelong memories together.” The Ripken Experience™ Elizabethtown joins Ripken Baseball’s lineup of youth sports destinations, including complexes in Aberdeen, Md.; Myrtle Beach, S.C.; and Pigeon Forge, Tenn. Across its facilities, clinics, and tournaments, Ripken Baseball hosts more than 120,000 participants and 350,000 guests from all 50 states and 12 countries annually. “Bringing The Ripken Experience™ and the Elizabethtown Sports Park together creates the ultimate win for families and players,” said Elizabethtown Mayor Jeff Gregory. “The excitement and energy behind this partnership are exactly why we feel it’s a perfect fit for us and we look forward to welcoming teams and their families to our community.” To start planning your trip to The Ripken Experience™ Elizabethtown, visit www.ripkenbaseball.com or give a Ripken Baseball teammate a call at 410-306-7575. About Elizabethtown Sports Park Elizabethtown Sports Park is a true destination for events of all sizes and caliber with three quads for baseball and softball, two championship-style turf fields, three large pavilions for events, and one accessible field with spectator seating. The mission of the sports park is to create experiences for people who yearn to be in the big leagues. This is the perfect place to play. A place for athletes to play like the pros. A place where everyone becomes a champion. The Ripken Experience is the premier baseball/softball partner with the sports park where we look to provide players, coaches, and families with the experiences and lifelong memories that will allow them to enjoy and play the game for as long as possible. For more information, visit: www.etownsports.com. About Ripken Baseball Ripken Baseball brings teammates, coaches, and families together through its Big-League Experiences, while teaching the values of the game, and how to play it the right way – the Ripken Way. Recently expanding the best experience in youth sports to satellite locations through Ripken Select Tournaments, Ripken Baseball continues to innovate the game through tournaments, camps, clinics, and spring training at their state-of-the-art baseball and softball facilities – The Ripken Experience™ Aberdeen (Maryland), The Ripken Experience™ Myrtle Beach (South Carolina), The Ripken Experience™ Pigeon Forge (Tennessee), and The Ripken Experience™ Elizabethtown (Kentucky). Contact Details Eric Nemeth nemeth@ericpr.com Company Website https://www.ripkenbaseball.com/

June 21, 2022 09:03 AM Eastern Daylight Time

The Connected Devices Making a Splash this Summer

News Media Group, Inc.

Contact Details News Media Group, Inc. Karl Wayne +1 334-440-6397 karl@newsmg.com Company Website https://newsmg.com/

June 21, 2022 08:00 AM Eastern Daylight Time

Video

VAPORESSO - The Vaper Expo UK New Vaping Models Launched

VAPORESSO

VAPORESSO launches TWO NEW products. VAPORESSO is putting innovation, reliability and style into the vape market with the launch of LUXE X and GEN PT60 | 80 S. Both kits, the LUXE X and GEN PT60 | 80 S feature the VAPORESSO innovative new heating technology COREX, which offers a more accurate flavour reproduction. It is the future of vaping with the patented Morph-Mesh Structure for more even heating and a stronger flavour boost to provide the most flavourful vapor. The cumulus cotton, formed by a complex microfibre structure, is designed to be fluffier for a higher liquid delivery, ensuring a more consistent and longer vape experience. The COREX technology adds to the VAPORESSO existing technology including the AXON Chip which is a smart and powerful vape chip to deliver more, know more and do more and the SSS Leak-resistant technology which means anti-leak and anti-mess. John Dunne, director general of the UK Vaping Industry Association, said: "The UK Government has set a goal for the country to be smoke free by 2030, with vaping playing a major role in this ambition. We support all our members, including Vaporesso, who are developing vape products that meet UK regulations and pose considerably less risk than smoking, helping the millions of smokers in the UK to quit their habits." LUXE X – Seeing the Future See the future with the chic and stylish design of the LUXE-X. With vapers at the heart of the design, the LUXE X features top technology to give more clouds and better flavour while looking great. GEN PT60 | 80 S – Beat the Tank The VAPORESSO GEN PT60 | 80 S, it is the first vape kit on the market to have an integrated top airflow and top filling system. It features leak free technology Double Top, Triple S, Quarter leak resistance, an industry first of its kind. The X-tank means one tank fits all kits offering full compatibility. Beat the Tank with the VAPORESSO GEN PT60 | 80 S, it features all this technology and style and is yet more cost effective than leading competitors. For Further information on VAPORESSO Contact: Grace Dewhurst - Phone – 07850 448 408 Email - grace@linkup-china.com Nia Thomas – Phone – 07723 019 767 Email - nia@linkup-china.com Background information of VAPORESSO VAPORESSO was created in 2015 and is dedicated to establishing a smoke-free world while raising the quality of life for our users. Based on our continuous innovation, strict quality control, and substantial commitment, VAPORESSO creates products that can fit all levels and styles of vapers. VAPORESSO strives to be able to help as many people as possible. The chairman and CEO Simon Lai was a smoker for 11 years, before turned to vaping. “When we started VAPORESSO, we had a big dream to make switching to vaping as easy as possible for everyone.” - CEO Simon Lai. SMOORE is the parent company of VAPORESSO, which is the largest global vaping device provider. SMOORE is the first to be publicly listed in the industry, with a valuation of over 25 billion USD, which set a significant milestone in history. Find more information in https://www.vaporesso.com/about-us Contact Details VAPORESSO Grace Dewhurst +44 7850 448408 grace@linkup-china.com Company Website https://www.vaporesso.com/about-us

June 21, 2022 07:57 AM Eastern Daylight Time

Image

NextFerm Technologies Announces First Commercial Production of ProteVin™, Its Vegan Protein

NextFerm Technologies Ltd.

This marks the achievement of first out of five strategic milestones set by the company for 2022 The Company expects to supply first orders of ProteVin™ in the coming weeks; Company is currently in dialogues with food and dietary supplement global companies for the integration of ProteVin™ in their alternative product lines NextFerm Technologies Ltd. (TASE:NXFR), a food-tech company developing ProteVin™, a vegan, yeast-based, non-GMO protein alternative and other innovative yeast-based nutrients, today announced the end of commissioning period of the commercial facility in Canada and first commercial production of ProteVin™, Its Vegan Protein. The operation of first commercial facility following commissioning and successful production of first batches mark the achievement of the first milestone out of five milestones set by the company for 2022. The Company continues to progress towards achieving the rest of its objectives for 2022, including delivery of initial orders received, increasing market demand for ProteVin™, receipt of additional purchase orders and expanding penetration into the global food market. In parallel, increasing commercial production capacity to an industrial scale of hundreds of tons per year in 2023. Boaz Noy, Chief Executive Officer of NextFerm, said: "Initiating commercial production of Protevin™, marks a significant milestone for the company moving forward from R&D phase to commercial phase. Achieving this milestone allows us to progress towards achieving the additional milestones we set for 2022. In the coming weeks, we expect to supply first orders of ProteVin™ for customers in the field of sports nutrition formulas." "The alternative protein market is the main growth engine of the global food industry, and we expect high demands for Protevin™, as a proprietary vegan protein source for a variety of alternative food products, with a rich amino acid composition similar to animal-based protein, highest digestibility factor (PDCAST=1) and neutral flavor." About NextFerm Technologies NextFerm Technologies, traded on the Tel Aviv Stock Exchange (TASE: NXFR) is a food-tech company engaged in the research, development, manufacturing and marketing of innovative, functional and vegan yeast-derived, non-GMO protein alternatives for various applications in the food and food supplement markets and the growing market for animal-derived protein alternatives. NextFerm's flagship product is ProteVin™, a vegan, yeast-derived protein alternative with nutritional value that is similar to animal-derived protein (Amino acid profile BCAA=21%, Leucine=9%, EAA=53% and high digestibility PDCAAS=1) and a neutral flavor, with no aftertastes that are typical of plant-based protein. ProteVin™ is designed for a variety of categories in the alternative protein market, which is estimated at USD 20 billion in terms of final products and at USD 5 billion in terms of raw materials with an annual growth rate of above 20%, including milk and dairy substitutes, meat substitutes and additional categories such as infant nutrition, adult nutrition, and sports nutrition. NextFerm has just commercialized the product as reported. Another product currently being sold is Astaferm®, an innovative astaxanthin-based antioxidant derived from yeast that has been sold in the US since the end of 2020 through well-established and leading brands in the food supplement market in the US. In July 2021, the Company received Regulatory marketing approval in Canada. The company has additional products which have been licensed to Lallemand, a global giant focused on yeast. For more information, visit the NextFerm website at: www.nextferm.com Legal Notice Regarding Forward-Looking Statements This announcement also includes forecasts, projections, assessments, estimates and other information which refer to future events and matters, the realization of which is uncertain and not exclusively under the Company’s control (forward-looking information). The main facts and data used to support this information are facts and data regarding the current position of the Company and its businesses (including the scope of sales and levels of profitability, manpower, commercial engagements and more), facts and data regarding the current global position of the Company’s operating segments (including industry-specific financial developments, environmental regulatory developments, the competitive environment, technological developments, the reinsurance market and more), and macro-economic facts and data (including the economic situation both in Israel and around the world, yields in the capital markets, social and state developments and more), all as known by the Company when publishing this announcement. The forward-looking information included above in this announcement is significantly based upon, in addition to the existing information held by the Company, on the Company’s current assessments and expectations of future developments vis-a-vis each one of the aforementioned parameters, and the interconnectedness of each one of these developments. The Company has no certainty that its forecasts and assessments will indeed eventuate, and the Company’s operating results may be materially different than the results assessed or implicit based on that set forth above, inter alia, as a result of a change in any of the aforementioned factors. Contact Details Investor and Media Contact Meirav Gomeh-Bauer +972 54-476-4979 meirav@bauerg.com Company Website https://www.nextferm.com/

June 20, 2022 10:05 AM Eastern Daylight Time

Lifestyle

NextFerm Technologies announces its first commercial delivery of ProteVin™, in the U.S

XPOINT ANNOUNCES MAJOR MILESTONE AS XPOINT VERIFY GOES LIVE IN CANADA

First-of-Its-Kind National Canine Cancer Registry Offers Ray of Hope to Dog Lovers

The Sweetest (And Most Popular) Fast Food Menu Items Just in Time for Summer

NO DOGS LEFT BEHIND TO HOST SILENT AUCTION & COCKTAIL PARTY BENEFITING RESCUE EFFORTS IN UKRAINE & HUNGARY

Ripken Baseball Adds Its Fourth Ripken Experience™ through Partnership with Elizabethtown Sports Park in Kentucky

The Connected Devices Making a Splash this Summer

VAPORESSO - The Vaper Expo UK New Vaping Models Launched

NextFerm Technologies Announces First Commercial Production of ProteVin™, Its Vegan Protein